Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy Volunteers
Clinical trial NCT04626414 · COMPLETED
Trial details
- NCT number
- NCT04626414
- Sponsor
- Shield Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-28
- Primary completion
- 2020-11-13
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.